• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
The Adenosinergic System: A Non-Dopaminergic Target in Parkinson's Disease

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson's Disease

Hardcover

Series: Current Topics in Neurotoxicity, Book 10

Medical ReferenceCognition

ISBN10: 3319202723
ISBN13: 9783319202723
Publisher: Springer
Published: Sep 15 2015
Pages: 337
Weight: 1.47
Height: 0.81 Width: 6.14 Depth: 9.21
Language: English
Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.

Also in

Medical Reference